Search by Drug Name or NDC

    NDC 64336-0175-08 Sinex Severe plus 650; 20; 12.5; 10 mg/30mL; mg/30mL; mg/30mL; mg/30mL Details

    Sinex Severe plus 650; 20; 12.5; 10 mg/30mL; mg/30mL; mg/30mL; mg/30mL

    Sinex Severe plus is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Procter & Gamble Manufacturing GmbH. The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 64336-0175
    Product ID 64336-175_cfe3090e-3aba-915e-e053-2a95a90a609c
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Sinex Severe plus
    Proprietary Name Suffix Vicks VapoCool
    Non-Proprietary Name acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, and phenylephrine hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form SOLUTION
    Route ORAL
    Active Ingredient Strength 650; 20; 12.5; 10
    Active Ingredient Units mg/30mL; mg/30mL; mg/30mL; mg/30mL
    Substance Name ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Procter & Gamble Manufacturing GmbH
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2022-12-31

    Package

    NDC 64336-0175-08 (64336017508)

    NDC Package Code 64336-175-08
    Billing NDC 64336017508
    Package 236 mL in 1 BOTTLE, PLASTIC (64336-175-08)
    Marketing Start Date 2018-07-10
    NDC Exclude Flag N
    Pricing Information N/A